Patents by Inventor Lijia Chen

Lijia Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240033260
    Abstract: The subject invention pertains to compositions comprising atropine at a concentration of greater than 0.025% to about 0.05% and methods of administering said compositions to a subject to inhibit or delay the onset of myopia in pre-myopic patients.
    Type: Application
    Filed: July 26, 2022
    Publication date: February 1, 2024
    Inventors: Cheuk Sing YAM, Chi Pui PANG, Lijia CHEN, Xiujuan ZHANG, Chee Yung Clement THAM
  • Publication number: 20230414595
    Abstract: An emulsion and use of an emulsion for pain relief comprising a local anesthetic, lecithin, oil and an aqueous phase, wherein the local anesthetic is non-covalent bound to the emulsion oil droplets and the emulsion is physically and chemically stable and the emulsion provides better safety, extended release pharmacokinetics and a prolonged duration of action of the local anesthetic.
    Type: Application
    Filed: September 6, 2023
    Publication date: December 28, 2023
    Applicant: CALI BIOSCIENCES US, LLC
    Inventors: Andrew Xian CHEN, Lijia CHEN, Damian McLOUD
  • Patent number: 11794248
    Abstract: A multi-stage gas atomization preparation method of titanium alloy spherical powder for a 3D printing technology includes the following steps: bar preparation and machining step, multi-stage gas atomization powder preparation step through vacuum induction, and powder screening step. The collision probability of the metal droplets at the gas atomization stage is reduced by controlling the gas atomization pressure and the feeding speed of the titanium alloy electrode bar in a hierarchical manner, so that the collaborative control of the particle size and the surface quality of the titanium alloy 3D printing powder in the gas atomization preparation process is realized.
    Type: Grant
    Filed: January 23, 2023
    Date of Patent: October 24, 2023
    Assignee: SHENYANG UNIVERSITY OF TECHNOLOGY
    Inventors: Ge Zhou, Zhipeng Zhang, Haoyu Zhang, Yaqian Chen, Nannan Zhang, Xiaojiao Zuo, Xin Wang, Siqian Zhang, Lijia Chen
  • Publication number: 20230234131
    Abstract: A multi-stage gas atomization preparation method of titanium alloy spherical powder for a 3D printing technology includes the following steps: bar preparation and machining step, multi-stage gas atomization powder preparation step through vacuum induction, and powder screening step. The collision probability of the metal droplets at the gas atomization stage is reduced by controlling the gas atomization pressure and the feeding speed of the titanium alloy electrode bar in a hierarchical manner, so that the collaborative control of the particle size and the surface quality of the titanium alloy 3D printing powder in the gas atomization preparation process is realized.
    Type: Application
    Filed: January 23, 2023
    Publication date: July 27, 2023
    Inventors: Ge ZHOU, Zhipeng ZHANG, Haoyu ZHANG, Yaqian CHEN, Nannan ZHANG, Xiaojiao ZUO, Xin WANG, Siqian ZHANG, Lijia CHEN
  • Publication number: 20220396549
    Abstract: Compounds that inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, and methods of using the same, are provided for treating disease.
    Type: Application
    Filed: December 7, 2020
    Publication date: December 15, 2022
    Inventors: Steven Fletcher, Maryanna Lanning, Lijia Chen
  • Publication number: 20220313669
    Abstract: Use of an emulsion for pain relief comprising a local anesthetic, lecithin, oil and an aqueous phase, wherein local anesthetic is non-covalent bound to the emulsion oil droplets and the emulsion is physically and chemically stable and said emulsion provides better safety, extended release pharmacokinetics and a prolonged duration of action of the local anesthetic.
    Type: Application
    Filed: July 7, 2021
    Publication date: October 6, 2022
    Applicant: CALI PHARMACEUTICALS, LLC
    Inventors: Andrew Xian CHEN, Lijia CHEN, Damian MCLOUD
  • Patent number: 10858316
    Abstract: Compounds that inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, and methods of using the same, are provided for treating disease.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: December 8, 2020
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Steven Fletcher, Maryanna Lanning, Lijia Chen
  • Publication number: 20180208554
    Abstract: Compounds that inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, and methods of using the same, are provided for treating disease.
    Type: Application
    Filed: July 8, 2016
    Publication date: July 26, 2018
    Inventors: Steven Fletcher, Maryanna Lanning, Lijia Chen
  • Publication number: 20110306999
    Abstract: This invention relates to the stimulation of a specific combination of 5 acupuncture points including EX-HN5 (taiyang), BL59 (fuyang), BL2 (cuanzhu), GV20 (baihui), and LI4 (hegu) and its effectiveness in improving vision in the treatment of anisometropic amblyopia.
    Type: Application
    Filed: June 7, 2011
    Publication date: December 15, 2011
    Applicant: The Chinese University of Hong Kong
    Inventors: DENNIS Shun Chiu LAM, Jianhao Zhao, Lijia Chen, Dorothy Shu Ping Fan, Johnson Yiu Nam Lau, Christopher Kai Shun Leung, Mingzhi Zhang, Chongren Zheng, Andrew Chung Tin Fok, Shirley Shu Liu